The RUNX are key regulators of lineage-specific gene expression in major developmental pathways. The expression of RUNX genes is tightly regulated, leading to a highly specific spatio/temporal expression pattern and to distinct phenotypes of gene knockouts. This review highlights the extensive structural similarities between the three mammalian RUNX genes and delineates how regulation of their expression at the levels of transcription and translation are orchestrated into the unique RUNX expression pattern.
Introduction
Three highly conserved human and mouse runt domain (RD) genes RUNX1, RUNX2 and RUNX3 (RUNX is used when description applies to both human and mouse, whereas Runx is used when findings involve only the mouse genes) were identified and localized on human chromosomes 21q22.12, 6p21 and 1p36.1 and on mouse chromosomes 16, 17 and 4, respectively (Bae et al., 1994 (Bae et al., , 1995 Levanon et al., 1994; Avraham et al., 1995; Calabi et al., 1995; Zhang et al., 1997a) . The RUNX are key regulators of lineage-specific gene expression in major developmental pathways. The genes arose early in evolution and maintained extensive structural similarities in mammals (Coffman, 2003; Levanon et al., 2003b; Rennert et al., 2003) . Gene knockout (KO) studies revealed that Runx1 is indispensable for definitive hematopoiesis (Okuda et al., 1996; Wang et al., 1996) , and Runx2 is essential for osteogenesis (Komori et al., 1997; Otto et al., 1997) . More recently, Runx3 was shown to play a role in neurogenesis and thymopoiesis Levanon et al., 2002 Levanon et al., , 2003b Taniuchi et al., 2002; Woolf et al., 2003) and in the control of cell proliferation and apoptosis of gastric epithelium (Li et al., 2002) . All RUNX proteins bind to the same DNA motif and activate or repress transcription of target genes through recruitment of common transcriptional modulators. In spite of this, the RUNX gene products have well-defined biological functions, which are reflected in the phenotypes of the corresponding KO mice. This occurrence is orchestrated through a tightly regulated spatio/temporal expression pattern of the RUNX genes.
Here we review the current knowledge about the structure and regulated expression of the three mammalian RUNX genes. Some aspects of these issues were previously reviewed (Ducy, 2000; Levanon et al., 2003a, b; Otto et al., 2003) . Due to space limitations, regulation of RUNX expression by alternative splicing and by post-translational modifications is not covered.
Genomic organization and regulatory elements of the RUNX genes RD-containing genes are found in phylogenetically diverse organisms (Ito and Bae, 1997; Bae and Lee, 2000; Kataoka et al., 2000; Eggers et al., 2002; KalevZylinska et al., 2002; Levanon et al., 2003b; Rennert et al., 2003; Stricker et al., 2003) (Figure 1a ). Analysis of DNA and protein sequence identified a nematode RD gene as the most primitive orthologue, suggesting that RUNX may have arisen in bilaterian metazoans (Rennert et al., 2003) . However, a final conclusion should wait until the complete annotated genomic sequence of the lower species Cnidarians becomes available. Lower organisms contain a single RUNX gene (Figure 1a ), but climbing the phylogenetic ladder to arthropods and vertebrates is accompanied by multiplicity of RUNX genes that occurred through gene duplication (Rennert et al., 2003) .
The three mammalian RUNX genes maintained extensive structural similarities Geoffroy et al., 1998; Xiao et al., 1998; Bangsow et al., 2001; Levanon et al., 2001b; Rennert et al., 2003) , which extend beyond the RUNX locus itself to include the neighboring paralogous genes CLIC and DSCR (Levanon et al., 2001b (Levanon et al., , 2003a Eggers et al., 2002) (Figure 1b) . Of the mammalian genes, RUNX3 is the smallest and contains the fewest number of exons, all of which are highly conserved among the three RUNX genes (Bangsow et al., 2001) (Figure 1b) . The structural similarities between the mammalian RUNX include genomic elements that are involved in expression regulation. Each of the three genes is transcriptionally regulated by two distantly located promoter regions, P1 (distal) and P2 (proximal) Stewart et al., 1997; Fujiwara et al., 1999; Drissi et al., 2000; Bangsow et al., 2001; Rini and Calabi, 2001; Telfer and Rothenberg, 2001; Xiao et al., 2001) . The P2 promoter is nested within a particularly large CpG island (Bangsow et al., 2001 ; Levanon et al., 2001b) (Figure 1d ), which is also conserved in Fugu (Eggers et al., 2002) . No such CpGrich region is found in the P1 promoter. Interestingly however, a highly conserved CpG island is located at the 3 0 -end within the last coding exon of the RUNX genes (Bangsow et al., 2001; Levanon et al., 2001b) . These The three lower nondesignated branches in the phylogenetic tree represent the animal groups (from bottom up) sponges, cnidarians (e.g. jellyfish) and acoelomates (e.g. flatworms). The more primitive animals contain one gene regulated by the P2 promoter (Rennert et al., 2003) . (b) Genomic organization of the human RUNX genes (common exons are shown in similar color). Chromosomal localizations and conserved neighboring genes (CLIC and DSCR) are depicted. The two promoters P1 and P2 and initiator ATGs are indicated. 5 0 UTRs are in yellow and orange and 3 0 UTRs are in blue. The proviral insertions in the CD2-MYC lymphomas are indicated by the name of the derived cell line (T6i, T47i, T1i) along with the chromosomal insertion sites (til-1, Dsi1) (Cameron et al., 2003) . (c) Scheme depicting the common structure of mammalian P1-5 0 UTR. It contains four exons; the middle two are alternatively spliced and designated as exon/introns. RR marks the two perfectly conserved RUNX-binding sites, underlined in the conserved 18 bp sequence 5 0 -CAACCACAGAACCACAAG-3 0 . (d) Scheme depicting the common structure of the mammalian P2-5 0 UTR. It spans one exon, which terminates with an in-exon splice site (AG) and is preceded by the intronic branch point signal CTRAY. The P2-5 0 UTRs contain IRES and are surrounded by an exceptionally large CpG island marked by the gray cloud Structure and expression of RUNX D Levanon and Y Groner highly conserved CpG islands at both ends of RUNX might be involved in tissue-specific expression of the genes (Ehrlich, 2003) , albeit the role of CpG islands in regulation of tissue-specific gene expression is still controversial. The CpG island of RUNX3 P2 promoter is hypermethylated in human and mouse gastric cancer cell lines and in primary human tumors (Guo et al., 2002; Li et al., 2002; Waki et al., 2003) . This may suggest that a tumorsuppressor function of RUNX3 is involved in the etiology of stomach cancer (Guo et al., 2002; Li et al., 2002; Waki et al., 2003) . Alternatively, it may reflect the increased activity of the DNA methyltransferase 1 (DNMT1) known to hypermethylate multiple CpG islands in gastric cancers (Etoh et al., 2004) . The P1 promoter of the three RUNX genes could be activated upon integration of murine leukemia virus (Figure 1b) , leading to enhanced expression and subsequently to the development of T-cell lymphoma in CD2-MYC transgenic mice (Stewart et al., 1997 (Stewart et al., , 2002 Cameron et al., 2003) . These findings suggest that RUNX3 could act both as a dominant oncogene in T-cell lymphoma, and as a tumor suppressor in stomach cancer. RUNX1 and RUNX3 expression is also affected by the Epstein-Barr virus (EBV) transcription factor EBNA-2. Following infection of B cells by EBV, expression of RUNX1 mRNA is reduced, whereas expression of RUNX3 mRNA is strikingly elevated, indicating that B-cell transformation by EBV is associated with upregulation of RUNX3 (Levanon et al., 1994; Spender et al., 2002, and our unpublished data) .
The P1-and P2-derived primary transcripts are processed into a diverse repertoire of alternatively spliced mRNA isoforms that are differentially expressed in various cell types and at different developmental stages. Considering that the P1 and P2 promoters generate different 5 0 -untranslated regions (5 0 UTRs) and thus distinct N-terminal coding regions, the repertoire of RUNX gene products is even larger (Figure 1b ). The combination of alternative promoters and elaborate splicing alternatives lead to production of a large number of protein isoforms with a variety of biological functions (Ogawa et al., 1993; Bae et al., 1994; Miyoshi et al., 1995; Tanaka et al., 1995b; Levanon et al., 1996 Levanon et al., , 2001b Mundlos et al., 1997; Stewart et al., 1997; Zhang et al., 1997b; Ben Aziz-Aloya et al., 1998; Thirunavukkarasu et al., 1998; Bangsow et al., 2001) . The significance of the various isoforms to RUNX biology remains to be elucidated.
Tissue-specific transcription control of RUNX genes
The P1 and P2 genomic regions of the three RUNX genes were evaluated for promoter features. Interestingly, both P1 and P2 contain several dispersed RUNXbinding sites, raising the possibility of cross-regulations between the RUNX genes Ducy et al., 1999; Drissi et al., 2000 Drissi et al., , 2002b Bangsow et al., 2001; Otto et al., 2003) . Significantly, in all the three human and mouse genes, two RUNX sites are identically located, at the beginning of the P1 5 0 UTR within a perfectly conserved sequence of 18 bp (Drissi et al., 2000; Bangsow et al., 2001) (Figure 1c ). Several in vitro studies have attributed either positive or negative transcriptional regulatory role to these sites through binding of RUNX proteins (Ducy et al., 1999; Drissi et al., 2000; Alliston et al., 2001) . However, the in vivo significance of these sites remains to be elucidated. The observations that in the various Runx KO mice expression of the other non-targeted Runx genes is not affected (Stricker et al., 2002; Yamashiro et al., 2002) may argue that these RUNX-binding sites do not always function in crossregulation.
Functional analyses using transfection assays have demonstrated that the P1 and P2 regions of the three genes possess promoter activity Fujiwara et al., 1999; Drissi et al., 2000; Bangsow et al., 2001; Rini and Calabi, 2001; Xiao et al., 2001; Zambotti et al., 2002) . In most cases, the activity was cell-type specific, with higher promoter-reporter readouts in cells that normally express the genes. However, detailed information about the positive and negative elements that regulate tissue-specific expression of RUNX genes in vivo is still missing.
In vitro studies by several groups evaluated the skeletal specific activity of RUNX2 P1 promoter. The region spanning nucleotides À92 to À78, which is entirely conserved in humans, rat and mouse, was identified as a vitamin D response element (VDRE). This element binds the VDR/RXR heterodimer and thereby mediates the direct suppressive effect of 1,25-(OH)2-Vitamin D3 on transcription of RUNX2 (Drissi et al., 2002a) . This region also harbors binding sites for AP1 and RUNX that mediate the response to selective estrogen receptor modulators (SERMS) (Tou et al., 2001) . However, the in vivo significance of this finding is not clear because responsiveness to estrogen was not demonstrated. Another highly conserved RUNX2 P1 region at À415 to À375 contains binding sites for NF1 and AP1 and acts as an osteoblast-specific enhancer (Zambotti et al., 2002) . The highly conserved RUNX binding sites between À89 and þ 46 are involved in regulation of RUNX2 expression (Ducy et al., 1999; Drissi et al., 2000; Alliston et al., 2001) (Figure 1c and see below).
Tissue-specific activity of one construct spanning 3 kb of Runx2 P1 promoter was evaluated in vivo using transgenic mice (Lengner et al., 2002) . Expression was detected in a subset of committed chondrocyte progenitors, which are involved in formation of the axial skeleton, but not in those of the appendicular limbs. Expression was not observed after birth, indicating that this promoter region lacks sequences conferring expression in hypertrophic chondrocytes and osteoblasts. Expression of Runx2 in mice deficient for the homeobox transcription factor Bapx1 is specifically downregulated in the developing axial skeleton (Tribioli and Lufkin, 1999) . Given the role of Bapx1 in the early prechondrogenic stages of axial skeleton development, it is tempting to speculate that Bapx1 regulates transcription Structure and expression of RUNX D Levanon and Y Groner of Runx2 during axial skeleton development. Finally, expression of Runx2 is also affected by changes in the expression of several other transcription factors including Hoxa-2, Msx2, Twist and PPARg2 (Kanzler et al., 1998; Lecka-Czernik et al., 1999; Satokata et al., 2000; Yousfi et al., 2002) . Future research might prove whether any of these transcription factors directly affects the promoters/enhancers of RUNX2.
Translation control of RUNX expression
As noted earlier, transcription of the RUNX genes is regulated at the transcriptional level by two promoters that give rise to mRNAs with distinct 5 0 UTRs (Figure 1b) . The two 5 0 UTRs (designated P1-5 0 UTR and P2-5 0 UTR) differ in size and structure, and each has characteristic features that are conserved between paralogues, even though the DNA sequences are not conserved (Bangsow et al., 2001; Levanon et al., 2003b) . The P1 5 0 UTR is usually shorter than the P2 5 0 UTR and contains four exons. The initiator ATG and the highly conserved P1 N-terminal peptide (MASy) are encoded in the fourth exon (Figure 1c) . The P2-5 0 UTR spans only one exon that harbors a highly conserved in-exon splice site and directs translation of the conserved P2 Nterminal peptide (MRIPV) (Figure 1d ).
The two 5 0 UTRs play an important role in translation regulation of RUNX expression. In RUNX1, the P1-5 0 UTR is 452 bp long and directs efficient translation in vitro. On the other hand, the P2-5 0 UTR is exceptionally long (1631 bp) and has structural characteristics that largely impede its in vitro translation activity. Functional analysis revealed that the P1-5 0 UTR directs capdependent translation control, whereas the P2-5 0 UTR regulates translation by an internal ribosomal entry site (IRES) mechanism (Pozner et al., 2000) . Recent studies revealed that in Runx2 both the P1 and P2 5 0 UTRs are able to mediate IRES-dependent translation control in vitro . It would be interesting to determine whether the CpG-rich P2 5 0 UTR of RUNX3 also possesses IRES elements and functions in translation regulation of RUNX3.
What could be the biological significance of capversus IRES-dependent translation control of RUNX? Initially discovered in picornaviruses, IRES elements were since found in many cellular mRNAs, including several regulatory proteins whose expression is tightly regulated (Vagner et al., 2001) . It is believed that IREScontaining mRNAs are translated at times when capdependent translation is physiologically impaired: during mitosis, differentiation or stress conditions. Thus, the existence of both cap-and IRES-dependent translation control in RUNX mRNAs adds an additional level at which expression of these genes is regulated. Moreover, as the P1-and P2-5 0 UTR-containing mRNAs encode RUNX proteins that differ at their N termini, the two translation control mechanisms can provide the flexibility needed for production of the relevant type of protein isoform in the appropriate amount at the proper time and in the right cell type. For example, RUNX1 P2-5 0 UTR mediates translation through IRES-dependent control during megakaryocytic differentiation in K562 cells at a time window when only the P2 promoter is transcriptionally active (Pozner et al., 2000) , highlighting the fine-tuned regulation and the coupling between transcriptional regulation and translation control. The IRES elements of Runx2 5 0 UTR1 and 5 0 UTR2 endued increased translation under genotoxic stress induced by mitomycin C and during osteoblastic maturation, further emphasizing the importance of translation control in RUNX expression (Sudhakar et al., 2001; Xiao et al., 2003) .
Signaling pathways regulating expression of RUNX genes
A number of investigators have studied the signaling pathways that regulate RUNX expression in response to external stimuli. The current wisdom is that RUNX not only functions as part of the TGF-b/BMP signaling pathway (Ito and Miyazono, 2003) , but that the genes are also regulated by components of this pathway. For example, TGF-b induces transcription of RUNX2 in the pluripotent mesenchymal precursor cell line C2C12 (Lee et al., 1999 , but downregulates Runx2 in primary osteoblasts and in the rat osteosarcoma cell line ROS 17/2.8 (Li et al., 1998; Alliston et al., 2001) . These data correspond with reports that TGF-b stimulates and inhibits early and terminal osteoblast differentiation, respectively (Bonewald and Dallas, 1994; Centrella et al., 1994) . Inhibition by TGF-b may be associated with repression of the Runx2 P1 promoter via the RUNXbinding sites located in the highly conserved À89 to þ 46 region mentioned earlier (Alliston et al., 2001) (Figure 1c ). This observation raises an interesting possibility that the P1 promoter region bearing the two RUNX-binding sites within the highly conserved 18 bp sequence serves as a TGF-b responsive element in all the three RUNX genes, through a RUNX autoregulatory loop.
Induction of osteoblastic differentiation by BMP2 in the C2C12 cell line involves increased expression of Runx2 mRNA preceded by upregulation of Smad5, JunB, activation of p38MAPK and induction of Dlx5 (Lee et al., 2003) . The promoter region, which confers response to BMP, has not been characterized. In transfection assays, a 5 0 P1 promoter region spanning up to 3 kb did not respond to BMP treatment (Banerjee et al., 2001; Xiao et al., 2001) .
Unlike RUNX2, much less is known about the involvement of TGF-b signaling in the expression of the two other RUNX genes. It was demonstrated that TGF-b induces the expression of Runx3, which then activates the Ig a promoter in the B cell line m 1.29 (Shi and Stavnezer, 1998) and that Runx1 expression is upregulated in Smad5-deficient mice (Liu et al., 2003) . Runx3 functions as a component of the TGF-b signaling cascade in dendritic cells and mediates their TGF-bdependent development and function in vivo (Fainaru et al., 2004) . TGF-b regulates the development of epithelium by inhibiting proliferation and inducing differentiation, and mice deficient for TGF-b1 display enhanced epithelial proliferation, resulting in hyperplasia (Crawford et al., 1998) . Runx1 is expressed in the epithelia of several developing organs including those affected in TGF-b1 KO mice (Levanon et al., 2001a; Yamashiro et al., 2002 , and see Table 1 ). Whether expression of Runx1 in these epithelia is regulated by TGF-b is an interesting open question.
Expression of RUNX genes is also affected by the FGF signaling pathway. In various cell lines, the response to FGF varies depending on the cell type. For example, FGF-dependent induction of Runx2 was observed in the mesenchymal pluripotent cell line C3H10T1/2 (Zhou et al., 2000) , whereas repression was observed in the rat osteosarcoma cell line ROS 17/ 2.8 (Tsuji and Noda, 2001 ). In the developing teeth, Runx2 is expressed in the dental mesenchyme and is regulated by FGF. Implantation experiments using beads soaked in FGF indicated that the mesenchymal expression of Runx2 is induced by FGF from the surrounding epithelium (D'Souza et al., 1999) .
Mice bearing a highly active mutant FGF receptor 1 (Fgfr1) exhibit an increase in Runx2 mRNA associated with enhanced osteoblast differentiation around the cranial sutures (Zhou et al., 2000) , providing an in vivo indication that Runx2 expression in osteoblast differentiation is regulated by components of FGF signaling pathway. In its capacity as an angiogenic growth factor, FGF induces Runx2 and Runx1 mRNA and protein expression in the murine endothelial cells MSS31 (Namba et al., 2000) . Basic FGF induces expression of Runx1 mRNA in the olfactory neuroblastoma cell line JFEN (Nibu et al., 2000) . Interestingly, Runx1 induction in this cell line was associated with induction of tyrosine kinase A (TrkA) expression (Nibu et al., 2000) . This Runx1-associated TrkA induction correlates with the specific in vivo expression of Runx1 and TrkA in the dorsal root ganglia nociceptive neurons (Levanon et al., 2001a . Angiogenesis-associated expression of Runx2 and Runx1 is also enhanced by IGF and VEGF, respectively (Namba et al., 2000; Sun et al., 2001) . Expression of Runx2 is also downregulated by TNFa as part of its inhibitory effect on osteoblast differentiation (Gilbert et al., 2002) .
The RUNX genes may also function as part of the retinoic acid (RA) signaling pathway, as expression of the three genes is upregulated by RA treatment (Tanaka et al., 1995a; Le et al., 1999; Jimenez et al., 2001) . Identification of the RUNX promoter regions involved in the induction by RA is still missing. Expression of Runx2 is also regulated by members of the hedgehog signaling pathway. Treatment of primary chondrocytes or the pluripotent cell line C3H10 T1/2 by sonic hedgehog resulted in activation of the Runx2 P1 promoter and in increased levels of Runx2 mRNA (Spinella-Jaegle et al., 2001; Takamoto et al., 2003) .
Recently, it was shown that the function of Drosophila runt domain gene Lozenge in fly hematopoiesis is regulated by notch signaling pathway (Lebestky et al., 2003) . As the functional hierarchy of the hematopoietic transcription factors GATA, FOG and RUNX is conserved between Drosophila and mammals (Lebestky et al., 2000; Fossett and Schulz, 2001; Evans et al., 2003) , the possibility arises that components of the notch signaling pathway also regulate expression of mammalian RUNX in the hematopoietic system. Consistent with this speculation, Runx1 and Runx3, as well as notch signaling, are involved in regulating the development and maturation of T cells (Deftos et al., 2000; Levanon et al., 2001a; Taniuchi et al., 2002; Woolf et al., 2003) .
Tissue-specific expression pattern of RUNX genes
The tightly regulated gene expression of RUNX is translated into a highly distinct tissue-specific expression of the three family members (Table 1) . Few exceptional cases of either spatial or temporal overlapping expression have also been described. Both Runx1 and Runx3 are highly expressed in cranial and dorsal root ganglia (DRG), but in different neuronal populations. Runx1 (Simeone et al., 1995; Levanon et al., 2001a Levanon et al., , 2002 . While information about the role of Runx1 in the DRG is still missing, the expression pattern of Runx3 in the DRG correlates well with the phenotypes of Runx3 KO mice Levanon et al., 2002) .
In mouse, embryo expression of Runx1 is first detected in definitive hematopoietic stem cells (HSC) and in endothelial cells at HSC emergence sites, that is, yolk sac, vitelline and umbilical arteries and aortagonad-mesonephros (AGM) as well as in the liver (North et al., 1999 (North et al., , 2002 Cai et al., 2000; Mukouyama et al., 2000) . These observations correlate well with the earlier findings that homozygous disruption of Runx1 results in a complete absence of fetal liver hematopoiesis and death of embryos between E11.5 and E12.5 from hemorrhages in the central nervous system (Okuda et al., 1996; Wang et al., 1996) . In adult hematopoietic system, Runx1 is highly expressed in several cell lineages including myeloid, B-and T-lymphoid cells (Lorsbach et al., 2003) , and Runx3 is expressed in mature dendritic cells (Fainaru et al., 2004) and T cells (Taniuchi et al., 2002; Woolf et al., 2003) .
All the three Runx proteins are expressed in the thymus Levanon et al., 1996 Levanon et al., , 2001a Komori et al., 1997; Hayashi et al., 2000 Hayashi et al., , 2001 Taniuchi et al., 2002; Woolf et al., 2003) . In the early developing thymus, expression pattern of Runx1 and Runx3 is very similar and appears to overlap at the cellular level (Levanon et al., 2001a) . Later, at E18, when thymus' regional demarcation of cortex and medulla becomes clear, expression of Runx1 is mainly in the cortex, whereas Runx3 is in both the cortex and medulla. In adults, expression of Runx1 is predominantly in the subcortical layer where immature thymocytes reside (Levanon et al., 2001a; Woolf et al., 2003) , whereas Runx3 is found mainly in the medulla where CD8/CD4 single-positive T cells develop (Levanon et al., 2001a; Taniuchi et al., 2002; Woolf et al., 2003) . At the cellular level, expression of Runx1 was detected in immature double-negative thymocytes (Taniuchi et al., 2002) and Runx3 in both double-negative cells and in mature single-positive CD8 cells (Taniuchi et al., 2002; Woolf et al., 2003) . The expression pattern of Runx1 and Runx3 in thymus corresponds to their in vivo function as positive and negative regulators in T-cell development during thymopoiesis (Taniuchi et al., 2002; Woolf et al., 2003) . Runx2 is also expressed during early thymic development in double-negative thymocytes and KO embryos display marked reduction in the overall number of thymocytes (Komori et al., 1997; Vaillant et al., 2002) . Consistent with these findings, enforced expression of Runx2 in transgenic mice affects early T-cell development (Vaillant et al., 2002) .
The expression of the three Runx proteins in the developing skeleton is intriguing. Although several groups carried out careful analyses, most of the available information relates to Runx2. Collectively, these analyses disclosed that all the three RUNX are expressed in cartilage. However, only Runx1 is expressed during bone development in immature cartilage and its expression in adults persists in permanent cartilage (Simeone et al., 1995; Levanon et al., 2001a; Lian et al., 2003) . Runx2 and Runx3 are both expressed in pre-and hypertrophic chondrocytes with Runx2 predominating in the latter (Inada et al., 1999; Kim et al., 1999; Enomoto-Iwamoto et al., 2001; Levanon et al., 2001a; Takeda et al., 2001; Choi et al., 2002; Stricker et al., 2002; Komori, 2003) . In osteoblasts, Runx2 is the major form (Komori et al., 1997; Komori, 2003; Otto et al., 1997) , Runx1 is expressed in early osteoblasts (Lian et al., 2003) and Runx3 was not detected (Stricker et al., 2002) . In membranous bone of the skull, expression of Runx2 is detected throughout development (Park et al., 2001; Choi et al., 2002) , while Runx1 is expressed in mesenchymal condensates, in the sutures and in immature cartilage (Yamashiro et al., 2002; Lian et al., 2003) . No detailed studies of Runx3 expression in membranous bone are available. The biological function of Runx2 in bone development, as reflected in the phenotype of Runx2 KO mice, correlates well with the expression pattern of the gene (Komori et al., 1997; Otto et al., 1997) . No such information is available about the role of Runx1 and Runx3 in the developing skeleton. Detailed analysis of this aspect in the recently derived CBF-b-deficient mice (Kundu et al., 2002; Miller et al., 2002; Yoshida et al., 2002) may provide information about the role of Runx1 in osteogenesis.
Structures that arise through ectodermal invagination such as salivary and mammary glands, and epidermal appendages including whiskers and teeth, express both Runx1 and Runx3, but again not in the same compartment. In whiskers and teeth, expression of Runx1 and Runx3 is confined to the epithelium and mesenchymal papilla, respectively (Levanon et al., 2001a; Yamashiro et al., 2002) . Expression of Runx2 is also found in the mesenchymal papilla of developing teeth (D'Souza et al., 1999) but is downregulated at the odontoblast stage, whereas expression of Runx3 persists (Yamashiro et al., 2002) . Epidermal appendages develop through regulated epithelial-mesenchymal cross-talk. Runx2 appears to participate in these interactions; its mesenchymal expression is induced by epithelial signals and is needed for epithelial morphogenesis (D'Souza et al., 1999) . During mouse development, the expression distribution of Runx1 and Runx3 into the epithelium and mesenchyme, respectively, is strictly maintained. Expression of Runx1, however, is broader than that of Runx3, as it is detected in several tissues where Runx3 is not expressed, including the epithelia of palatal ridges, bronchi, respiratory and olfactory mucosa, and in the mucosa of the esophagus and stomach (Simeone et al., 1995; Levanon et al., 2001a) . Runx1 is also expressed in mesenchyme of several other organs, as well as in the heart and in the central nervous system (Levanon et al., 2001a) .
Perspective
Expression of RUNX genes is tightly regulated at the transcriptional and post-transcriptional levels. Consequently, the genes display distinct tissue-and developmental-specific expression. Details about the molecular mechanisms that control the spatial and temporal patterns of RUNX expression during growth, differentiation and development are still lacking. The genomic architecture of the three mammalian genes is highly similar, as are the basic regulatory elements. As the RUNX family appeared early in evolution and the mammalian genes maintain structural similarities, it is conceivable that the control element enduing tissue-and timing-specific expression evolved concomitantly with the growing repertoire of RUNX-specific biological tasks. Information about the expression patterns of RUNX during development and about the signaling pathways in which the genes participate will help to identify the tissue-and stage-specific regulatory elements and allow to better understand how these important regulators are regulated.
